NOXBOX LTD has recalled approximately 1,667 units of the NOxBOXi Nitric Oxide Delivery System (Model NOXBOXI) because the internal sample pump has shown high failure rates. This defect requires the sample pump to be replaced to ensure the device can properly monitor and deliver nitric oxide therapy. No injuries or incidents have been reported in connection with this issue, and the manufacturer is initiating corrections to fix the problem.
Failure of the internal sample pump can prevent the system from accurately measuring or delivering the required dose of nitric oxide. This can lead to an interruption in respiratory therapy, potentially resulting in serious health complications for patients who depend on the device for stabilized breathing.
Replacement of the internal Sample Pump due to high failure rates.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.